Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms

被引:106
作者
Laitinen, J
Taponen, S
Martikainen, H
Pouta, A
Millwood, I
Hartikainen, AL
Ruokonen, A
Sovio, U
McCarthy, MI
Franks, S
Järvelin, MR
机构
[1] Oulu Reg Inst Occupat Hlth, Oulu, Finland
[2] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland
[3] Univ Oulu, Dept Obstet & Gynecol, Oulu, Finland
[4] Oulu Univ Hosp, Oulu, Finland
[5] Univ London Imperial Coll Sci & Technol, Dept Epidemiol & Publ Hlth, Fac Med, London, England
[6] Univ Oulu, Dept Clin Chem, Oulu, Finland
[7] Univ London Imperial Coll Sci & Technol, Genet & Genom Res Inst, Fac Med, London, England
[8] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[9] Univ London Imperial Coll Sci Technol & Med, Dept Reprod Sci & Med, Inst Reprod & Dev Biol, London, England
基金
芬兰科学院;
关键词
menstrual disturbances; hirsutism; polycystic ovary syndrome; body mass index; abdominal obesity; cohort studies; longitudinal studies;
D O I
10.1038/sj.ijo.0802301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To study the association between body size from birth to adulthood and self-reported symptoms of polycystic ovary syndrome (PCOS), particularly hirsutism and menstrual disturbances. DESIGN: Longitudinal, population-based study of a cohort of women born in 1966 in northern Finland. The study population included 2007 women who were not pregnant and did not use hormonal contraception. Of these 528 (26%) had self-reported symptoms of PCOS. RESULTS: Weight at birth, gestational age, being small for gestational age or growth retardation at birth were not associated with PCOS symptoms at 31 y. An increased risk of PCOS symptoms was observed among women with abdominal obesity (waist/hip ratio >85th percentile) at 31 y who had normal weight in adolescence and were overweight (body mass index (BMI) 25.0-29.9 kg/m(2)) or obese (BMI>30.0kg/m(2)) at 31 y (relative risk (RR) (95% CI) 1.44(1.10-1.89)), and among women with abdominal obesity who were overweight or obese at both 14 and 31 y (1.71 (1.30-2.24)). A total of 30% and 41% of the women with PCOS symptoms in these groups could be attributed, respectively, to overweight, obesity and abdominal obesity at 31 y. CONCLUSIONS: These results suggest that obesity in adolescence and in adulthood, and also weight gain after adolescence, particularly in the presence of abdominal obesity, are associated with self-reported PCOS symptoms in adulthood. Thus, based on the results from intervention studies treating PCOS and the results of this study, the prevention of obesity and abdominal obesity is important among young women.
引用
收藏
页码:710 / 715
页数:6
相关论文
共 38 条
[1]  
[Anonymous], 1998, OBESITY PREVENTING M, P276
[2]   METABOLIC FEATURES OF POLYCYSTIC-OVARY-SYNDROME ARE FOUND IN ADOLESCENT GIRLS WITH HYPERANDROGENISM [J].
APTER, D ;
BUTZOW, T ;
LAUGHLIN, GA ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (10) :2966-2973
[3]   ACCELERATED 24-HOUR LUTEINIZING-HORMONE PULSATILE ACTIVITY IN ADOLESCENT GIRLS WITH OVARIAN HYPERANDROGENISM - RELEVANCE TO THE DEVELOPMENTAL PHASE OF POLYCYSTIC OVARIAN SYNDROME [J].
APTER, D ;
BUTZOW, T ;
LAUGHLIN, GA ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :119-125
[4]   INSULIN STIMULATES ANDROGEN ACCUMULATION IN INCUBATIONS OF OVARIAN STROMA OBTAINED FROM WOMEN WITH HYPERANDROGENISM [J].
BARBIERI, RL ;
MAKRIS, A ;
RANDALL, RW ;
DANIELS, G ;
KISTNER, RW ;
RYAN, KJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :904-910
[5]   TYPE 2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS, HYPERTENSION AND HYPERLIPEMIA (SYNDROME-X) - RELATION TO REDUCED FETAL GROWTH [J].
BARKER, DJP ;
HALES, CN ;
FALL, CHD ;
OSMOND, C ;
PHIPPS, K ;
CLARK, PMS .
DIABETOLOGIA, 1993, 36 (01) :62-67
[6]   Fetal growth, length of gestation, and polycystic ovaries in adult life [J].
Cresswell, JL ;
Barker, DJP ;
Osmond, C ;
Egger, P ;
Phillips, DIW ;
Fraser, RB .
LANCET, 1997, 350 (9085) :1131-1135
[7]  
DAHLGREN E, 1992, FERTIL STERIL, V57, P505
[8]   Weight gain and the risk of developing insulin resistance syndrome [J].
Everson, SA ;
Goldberg, DE ;
Helmrich, SP ;
Lakka, TA ;
Lynch, JW ;
Kaplan, GA ;
Salonen, JT .
DIABETES CARE, 1998, 21 (10) :1637-1643
[9]  
Franks S, 1996, Rev Reprod, V1, P47, DOI 10.1530/ror.0.0010047
[10]   MEDICAL PROGRESS - POLYCYSTIC-OVARY-SYNDROME [J].
FRANKS, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13) :853-861